Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

EU-funded project develops new type of vaccine to tackle HIV virus infection

AIDS research has attempted many strategies to tackle the HIV virus infection. Now, a new type of vaccine developed within an EU-funded project, called EuroNeut-41, is based on one of the envelope proteins of the HIV virus, called the gp41 protein. What makes it interesting it that it is directly responsible for the fusion of the HIV virus into human cells. By integrating the gp41 protein into the vaccine, researchers try to trigger the production of antibodies that would block the entrance of HIV into human cells

27 Nov 2013

Research: Human neural stem cells could improve blood flow in critical limb ischemia

New research has shown human neural stem cells could improve blood flow in critical limb ischemia through the growth of new vessels. Critical limb ischemia is a disease that severely obstructs arteries and reduces the blood flow to legs and feet. CLI remains an unmet clinical problem and with an ageing population and the rise in type II diabetes, the incidence of CLI is expected to increase.

27 Nov 2013

Virginia Tech professor named AAAS Fellow for contributions to plant science

John Jelesko, an associate professor of plant pathology, physiology and weed science in the College of Agriculture and Life Sciences at Virginia Tech, has been named a Fellow of the American Association for the Advancement of Science.

26 Nov 2013

Global health organizations join forces to raise awareness on dangers of fake medicines

Fake medicines increasingly put patients and the general public at risk across the world. In response to this challenge, ten partners who represent healthcare professionals, disease-specific organizations, product-development partnerships, foundations, international financing institutions, as well as the research-based pharmaceutical industry have joined forces to raise awareness about the dangers of fake medicines.

26 Nov 2013

Garlic compounds can kill foodborne pathogen present in infant formula powder

Garlic may be bad for your breath, but it's good for your baby, according to a new study from the University of British Columbia.

26 Nov 2013

UT Arlington assistant professor develops computational model to predict epileptic seizure

A UT Arlington assistant engineering professor has developed a computational model that can more accurately predict when an epileptic seizure will occur next based on the patient's personalized medical information.

22 Nov 2013

Covagen, TRL expand research collaboration to generate bispecific FynomAb

Covagen and Tanabe Research Laboratories U.S.A, Inc., a fully owned subsidiary of Mitsubishi Tanabe Pharma Corporation, today announced that they expanded their strategic research collaboration. MTPC and TRL have nominated a first bispecific FynomAb for formal preclinical development which triggered an undisclosed milestone payment. MTPC and TRL also exercised an option for a second bispecific FynomAb program based on the parties' research and licensing agreement signed in October 2012.

21 Nov 2013

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

BBI Solutions, a world leader in immunoassay development and contract manufacturing, recently launched its unique range of Recombinant Fab Monoclonal Antibodies at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo, on July 28-August 31, 2013, in Houston, Texas.

19 Nov 2013

Kiadis reports successful Phase II enrollment for CR-AIR-007 ATIR blood cancer treatment study

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces the successful Phase II enrollment of approximately ten patients of whom the majority have already been transplanted and received ATIR™. Kiadis Pharma's lead program, ATIR™, is a cell-based product designed to enable stem cell transplantations from partially mismatched (haploidentical) family donors for blood cancer patients who do not have a standard of care stem cell donor available. Topline data from the trial (CR-AIR-007) is expected in the first half of 2014.

18 Nov 2013

Viewpoints: 'Nation takes stock' of Obama and his health law; Noonan says now is time to hold back Obamacare; Obama needs to be resolute

President Obama has come up with a modest fix for a self-inflicted political wound: his repeated -; and wrong -; assertions that Americans would be able to keep their health insurance plans if they wanted to under the health care reform law (11/14).

16 Nov 2013

GoInformatics, TeselaGen form strategic partnership to offer cutting-edge biodesign automation tools

GoInformatics and TeselaGen have announced a strategic partnership to offer a state-of-the-art Biological Design Automation and Scientific Data Management platform. With a secure repository to collect, organize, and store research information, the integrated cloud-based platform will enable scientists advance their research at a much faster pace.

16 Nov 2013

WuXi PharmaTech subsidiary enters into supply arrangement with Pharmacyclics

WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that its wholly owned subsidiary Shanghai SynTheAll Pharmaceutical Co., Ltd., has entered into a supply arrangement with Pharmacyclics, Inc.

15 Nov 2013

TPI’s revenue decreases 8.1% to $14.8 million in first quarter fiscal year 2014

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the first quarter fiscal year 2014.

15 Nov 2013

Medix Biochemica to launch antibody production services for IVD assays at MEDICA 2013

Medix Biochemica, producer of monoclonal antibodies for the global IVD industry and diagnostic rapid tests, is presenting its MedixMAB by Design and MedixMAB Manufacturing antibody production services to the European market at MEDICA 2013, Dusseldorf, Germany, 20-23 November, Hall 3, Stand F44.

14 Nov 2013

Pro-Dex fiscal 2014 first quarter sales decrease 26% to $2.6 million

PRO-DEX, INC. today announced financial results for its fiscal 2014 first quarter ended September 30, 2013.

14 Nov 2013

OvaScience reports net loss of $6.9 million in Q3 2013

OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended September 30, 2013, as well as recent highlights.

14 Nov 2013

SCHOTT announces the rebranding of its glass syringes

...

13 Nov 2013

New biomedical instrument anticipated to help breakthroughs in animal, human health

A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.

13 Nov 2013

Agilent collaborates with Baylor College of Medicine to provide CGH microarrays to researchers

Agilent Technologies Inc. has announced it is collaborating with Baylor College of Medicine's Medical Genetics Laboratories to provide customized CGH (comparative genomics hybridization) microarrays to researchers worldwide. Six new microarray designs unite the power of Baylor's data-rich expertise in genetics research with Agilent's microarray manufacturing capabilities to enable advanced discoveries in cancer and cytogenetics research.

12 Nov 2013

Pharmaceutical vials that further minimize delamination risk unveiled by SCHOTT

SCHOTT today unveiled SCHOTT Vials DC, which further minimize the risk of glass delamination. The company optimized its manufacturing process to ensure that SCHOTT Vials DC have a more homogeneous surface and high chemical stability, and tests the vials using the SCHOTT Delamination Quicktest, a first-of-its-kind, patented test method that documents a container’s tendency toward delamination.

12 Nov 2013

Manufacturing News and Research

Further Reading

EU-funded project develops new type of vaccine to tackle HIV virus infection

Research: Human neural stem cells could improve blood flow in critical limb ischemia

Virginia Tech professor named AAAS Fellow for contributions to plant science

Global health organizations join forces to raise awareness on dangers of fake medicines

Garlic compounds can kill foodborne pathogen present in infant formula powder

UT Arlington assistant professor develops computational model to predict epileptic seizure

Covagen, TRL expand research collaboration to generate bispecific FynomAb

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

Kiadis reports successful Phase II enrollment for CR-AIR-007 ATIR blood cancer treatment study

Viewpoints: 'Nation takes stock' of Obama and his health law; Noonan says now is time to hold back Obamacare; Obama needs to be resolute

GoInformatics, TeselaGen form strategic partnership to offer cutting-edge biodesign automation tools

WuXi PharmaTech subsidiary enters into supply arrangement with Pharmacyclics

TPI’s revenue decreases 8.1% to $14.8 million in first quarter fiscal year 2014

Medix Biochemica to launch antibody production services for IVD assays at MEDICA 2013

Pro-Dex fiscal 2014 first quarter sales decrease 26% to $2.6 million

OvaScience reports net loss of $6.9 million in Q3 2013

SCHOTT announces the rebranding of its glass syringes

New biomedical instrument anticipated to help breakthroughs in animal, human health

Agilent collaborates with Baylor College of Medicine to provide CGH microarrays to researchers

Pharmaceutical vials that further minimize delamination risk unveiled by SCHOTT

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News